Pet medicine shortage leaves epileptic dogs at risk
Vets need to find an alternative for dogs currently on phenobarbitone, Sedabarb or Lethyl Vets have warned pet owners of a nationwide shortage of the anti-seizure drug phenobarbitone, as the manufacturer Sun Pharma works to restart production at an upgraded facility.
Sun Pharma confirmed on Sunday that its anti-seizure medication Sedabarb remained out of stock across South Africa, more than two weeks after vets first warned that dogs with epilepsy faced a life-threatening shortage of phenobarbitone-based treatments.
Facility upgrade blamed for delay On Sunday, Sun Pharma CEO Malcolm Brown said the shortage followed a large-scale upgrade of the company’s Oral Solid Dosage manufacturing facility, which was carried out to meet quality and regulatory standards.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
